{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:55:39Z","timestamp":1783407339107,"version":"3.54.6"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":782,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008980","name":"Medical College of Wisconsin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002418","name":"Intel Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["OT3HL147741"],"award-info":[{"award-number":["OT3HL147741"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R21HL140314"],"award-info":[{"award-number":["R21HL140314"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL128568"],"award-info":[{"award-number":["U01HL128568"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U24HL138660"],"award-info":[{"award-number":["U24HL138660"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["N00014-20-1-2705"],"award-info":[{"award-number":["N00014-20-1-2705"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["N00014-18-1-2888"],"award-info":[{"award-number":["N00014-18-1-2888"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["N00014-18-1-2850"],"award-info":[{"award-number":["N00014-18-1-2850"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["HHSH250201700006C"],"award-info":[{"award-number":["HHSH250201700006C"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["HHSH250201700007C"],"award-info":[{"award-number":["HHSH250201700007C"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["SC1MC31881-01-00"],"award-info":[{"award-number":["SC1MC31881-01-00"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006823","name":"Boston Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016875","name":"Chimerix","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["U24CA076518"],"award-info":[{"award-number":["U24CA076518"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jtct.2021.01.022","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T20:41:21Z","timestamp":1611866481000},"page":"345-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Qualitative Analysis of State Medicaid Coverage Benefits for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Sickle Cell Disease (SCD)"],"prefix":"10.1016","volume":"27","author":[{"given":"Tatenda G.","family":"Mupfudze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime M.","family":"Preussler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Sees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"SanCartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staci D.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2021.01.022_bib0001","series-title":"Evidence-Based Management of Sickle Cell Disease Expert Panel Report","year":"2014"},{"key":"10.1016\/j.jtct.2021.01.022_bib0002","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.hemonc.2017.05.008","article-title":"Hematopoietic stem cell transplantation for sickle cell disease: the changing landscape","volume":"10(4)","author":"Kassim","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2021.01.022_bib0003","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bjh.12024","article-title":"High one year mortality in adults with sickle cell disease and end-stage renal disease","volume":"159","author":"McClellan","year":"2012","journal-title":"Br J Haematol"},{"issue":"19","key":"10.1016\/j.jtct.2021.01.022_bib0004","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMc1411133","article-title":"Transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"van der Land","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jtct.2021.01.022_bib0005","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/pbc.22069","article-title":"Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States","volume":"53","author":"Mvundura","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"10.1016\/j.jtct.2021.01.022_bib0006","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","article-title":"Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation","volume":"129","author":"Gluckman","year":"2017","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jtct.2021.01.022_bib0007","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(19)30154-1","article-title":"Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study","volume":"6","author":"Eapen","year":"2019","journal-title":"Lancet Haematol"},{"issue":"36","key":"10.1016\/j.jtct.2021.01.022_bib0008","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1200\/JCO.2014.56.3452","article-title":"American Society of Clinical Oncology policy statement on Medicaid reform","volume":"32","author":"Polite","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2021.01.022_bib0009","unstructured":"Centers for Medicare & Medicaid Services. Allogeneic hematopoietic stem cell transplant for sickle cell disease. Available at: https:\/\/www.cms.gov\/Medicare\/Coverage\/Coverage-with-Evidence-Development\/allo-scd. Accessed February 9, 2021."},{"issue":"4","key":"10.1016\/j.jtct.2021.01.022_bib0010","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1200\/JOP.2013.001155","article-title":"Variation in Medicaid coverage for hematopoietic cell transplantation","volume":"10","author":"Preussler","year":"2014","journal-title":"J Oncol Pract"},{"issue":"2","key":"10.1016\/j.jtct.2021.01.022_bib0011","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MLR.0000000000000855","article-title":"Insurance type and access to health care providers and appointments under the Affordable Care Act","volume":"56","author":"Alcala","year":"2018","journal-title":"Med Care"},{"issue":"4","key":"10.1016\/j.jtct.2021.01.022_bib0012","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/pop.2016.0075","article-title":"Comparing emergency department use among Medicaid and commercial patients using all-payer all-claims data","volume":"20","author":"Kim","year":"2017","journal-title":"Popul Health Manag"},{"issue":"7","key":"10.1016\/j.jtct.2021.01.022_bib0013","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/jnci\/djaa048","article-title":"Health insurance coverage disruptions and cancer care and outcomes: systematic review of published research","volume":"112","author":"Yabroff","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtct.2021.01.022_bib0014","unstructured":"Wilson-Frederick SM, Hulihan M, Anderson KK. Prevalence of sickle cell disease among Medicaid beneficiaries in 2012. Available at: https:\/\/www.cms.gov\/About-CMS\/Agency-Information\/OMH\/Downloads\/Data-Highlight-16-Sickle-Cell-Disease.pdf. Accessed February 9, 2021."},{"key":"10.1016\/j.jtct.2021.01.022_bib0015","unstructured":"Be the Match. Transplant benefits & coverage. Available at: https:\/\/payer.bethematchclinical.org\/transplant-benefits-and-coverage\/. Accessed February 9, 2021."},{"issue":"4","key":"10.1016\/j.jtct.2021.01.022_bib0016","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/geront\/gns141","article-title":"Engaging consumers in Medicaid nursing home reimbursement policy: lessons from New York and Minnesota","volume":"53","author":"Miller","year":"2013","journal-title":"Gerontologist"},{"issue":"3","key":"10.1016\/j.jtct.2021.01.022_bib0017","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"key":"10.1016\/j.jtct.2021.01.022_bib0018","unstructured":"Kaiser Family Foundation. Medicaid benefits: outpatient hospital services. Available at: https:\/\/www.kff.org\/medicaid\/state-indicator\/outpatient-hospital-services\/?currentTimeframe=0&sortModel=%7B%22colId%22: %22Location%22,%22sort%22:%22asc%22%7D. Accessed February 9, 2021."},{"key":"10.1016\/j.jtct.2021.01.022_bib0019","unstructured":"Kaiser Family Foundation. Medicaid benefits: physician services. Available at:https:\/\/www.kff.org\/medicaid\/state-indicator\/physician-services\/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%?>22sort%22:%22asc%22%7D. Accessed February 9, 2021."},{"key":"10.1016\/j.jtct.2021.01.022_bib0020","unstructured":"Kaiser Family Foundation. Medicaid benefits: prescription drugs. Available at: https:\/\/www.kff.org\/medicaid\/state-indicator\/prescription-drugs\/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%?>22,%22sort%22:%22asc%22%7D. Accessed February 9, 2021."},{"issue":"6","key":"10.1016\/j.jtct.2021.01.022_bib0021","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jhealeco.2003.07.001","article-title":"The link between public and private insurance and HIV-related mortality","volume":"22","author":"Bhattacharya","year":"2003","journal-title":"J Health Econ"},{"issue":"8","key":"10.1016\/j.jtct.2021.01.022_bib0022","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/cncr.20954","article-title":"Cancer, Medicaid enrollment, and survival disparities","volume":"103","author":"Bradley","year":"2005","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jtct.2021.01.022_bib0023","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1186\/s12913-018-3516-9","article-title":"Qualitative perspectives of primary care providers who treat Medicaid managed care patients","volume":"18","author":"Gordon","year":"2018","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"10.1016\/j.jtct.2021.01.022_bib0024","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/pds.4365","article-title":"Internal validation of Medicaid Analytic eXtract (MAX) data capture for comprehensive managed care plan enrollees from 2007 to 2010","volume":"27","author":"Li","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.jtct.2021.01.022_bib0025","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/MPH.0000000000001297","article-title":"Barriers to medication access in pediatric oncology in the United States","volume":"41","author":"Kelly","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.jtct.2021.01.022_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26339","article-title":"Medication prior authorization in pediatric hematology and oncology","volume":"64","author":"Dickens","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"10.1016\/j.jtct.2021.01.022_bib0027","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/acr.24062","article-title":"Treatment delays associated with prior authorization for infusible medications: a cohort study","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721006308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721006308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:59:39Z","timestamp":1763002779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636721006308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2666636721006308"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2021.01.022","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Qualitative Analysis of State Medicaid Coverage Benefits for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Sickle Cell Disease (SCD)","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2021.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}